Clinical trial
HLA-B35 Alleles and AIDS
NCT00340223 · National Cancer Institute (NCI), NIH · Withdrawn
Key facts
| NCT number | NCT00340223 |
|---|---|
| Title | HLA-B35 Alleles and AIDS |
| Official title | Comparison of HIV-1 Epitopes That May be Recognized by HLA-B*3501 (PY) and -B*3503 (Px) Early After Seroconversion and After Development of AIDS |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | HIV-1, AIDS |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Jun 21, 2006 |
| Last update posted | May 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: